Clinical Outcomes of 50% Autologous Serum Eye Drops for Contact Lens-Induced Limbal Stem Cell Deficiency: A Staging-Based Evaluation.

The severity of corneal epithelial defect (corneal epithelial defect) and corneal neovascularization (neovascularization) significantly decreased after treatment (p < 0.05, respectively), and corneal opacity showed a decreasing trend without statistical significance.

At 3 months, BCVA improved in 64.3% of eyes, with the mean value decreasing significantly from 0.65± 0.41 to 0.51 ± 0.46 logMAR (mean change: -0.14 ± 0.22; p = 0.032).